| Bioactivity | Ilunocitinib (compound 27) is a JAK inhibitor (extracted from patent WO2009114512A1)[1]. | ||||||||||||
| Name | Ilunocitinib | ||||||||||||
| CAS | 1187594-14-4 | ||||||||||||
| Formula | C17H17N7O2S | ||||||||||||
| Molar Mass | 383.43 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. James D. Rodgers, et al. Azetidine and cyclobutane derivatives as jak inhibitors. Patent. WO2009114512A1. |